The Nuclear Medicine Radioisotopes Market report forecast 2019-2024 is a professional and detailed study on the present state also focuses on the major drivers, Nuclear Medicine Radioisotopes business strategists and effective growth for the key players. Global Nuclear Medicine Radioisotopes Industry also provides granular analysis of the Nuclear Medicine Radioisotopes market dynamics, share, segmentation, revenue forecasts and facilitate better decision-making.
Ask for Sample PDF of Nuclear Medicine Radioisotopes Market Report at https://absolutereports.com/enquiry/request-sample/13999554
Increasing cases of cancer and cardiac ailments are the major drivers for the nuclear medicines radioisotopes market. Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. They meet the statutory definition of drugs under Section 1861(t) of the Social Security Act because they either are included in the various drug compendia or recognized by hospital medical staff as drugs. Historically, nuclear medicine has been well established as a therapeutic modality for thyroid cancer, Graves’ disease, hyperthyroidism, and bone pain palliation, associated with skeletal metastasis. Hence, the broadening applications of radioisotopes are expected to propel market growth.
Scope of the Report
As per the Scope of the Report, medical radioisotopes are defined as safe radioactive substances that are primarily used in the diagnosis of medical conditions. These radioisotopes, used in a diagnosis, emit gamma rays of energy that are sufficient to escape from the body. The rays also have a short half-life, which is apt, since the rays can decay as soon as the imaging is completed.
Nuclear Medicine Radioisotopes Market by Top Manufacturers: – – Agfa-Gevaert Group, Cardiarc Ltd, Digirad Corporation, CMR Naviscan (Gamma Medica Inc.), GE Healthcare, Positron Corp., Segami Corporation, Siemens Healthcare GmBH, Nordion (Canada) Inc., NTP Radioisotopes SOC Ltd, Bracco S.p.A, Cardinal Health Inc., Curium
Analysis and Key Opportunities of Nuclear Medicine Radioisotopes Market Report: Extensive analysis of the Global market, by component, helps in understanding the components of the Market that are currently used along with the variants that would gain prominence in the future. Nuclear Medicine Radioisotopes market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.
Key Market Trends
Oncology Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Radiotherapy can be used to treat various medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. PET, which is a precise technique, uses isotopes produced in a cyclotron. It is highly used for a clinical role in oncology, with fluorine-18 as the tracer, and is proven to be the most accurate non-invasive method of detecting and evaluating most cancers. A new field for cancer treatment is targeted alpha therapy (TAT) or alpha radio-immunotherapy, especially for the control of dispersed cancers. Nuclear medicine is proven effective in oncology in several roles, spanning the course of the disease, including the characterization of a mass, staging, restaging, and monitoring of therapeutic response. Hence, owing to these associated factors, the oncology segment is expected to exhibit the fastest growth rate.
North America captured the Largest Market Share and is Expected to Retain its Dominance
North America captured the largest market share in the nuclear medicine radioisotopes market. The United States was the largest contributor to the revenue of North America, and is expected to retain its dominance owing to the higher procedural volume and increasing adoption of the nuclear medicine isotopes for various therapeutic applications. Bone scintigraphy is the next most common nuclear medicine procedure performed in the United States, but it represents only 17% of procedures. The volume of PET procedures in the United States is approximately 1.5 million per year. Oncology accounts for more than 90% of the PET and PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Canada is the largest producer of Technetium-99m. Due to the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. 80% of the nuclear medicine market is driven by Tc-99m in various diagnostic procedures and treatments. Considering these factors associated with the United States and Canada, the North American market is expected to experience accelerated growth rates and market dominance.
Inquire More and Share Questions If Any Before the Purchase on This Report At: https://www.absolutereports.com/enquiry/pre-order-enquiry/13999554
Some Major Point cover in this Nuclear Medicine Radioisotopes report are: –
What will the market growth rate, Overview and Analysis by Type of Nuclear Medicine Radioisotopes Market in 2023?
What are the key factors driving, Analysis by Applications and Countries Global Nuclear Medicine Radioisotopes industry?
What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Manufacturers Profiles of Nuclear Medicine Radioisotopes?
Who are Opportunities, Risk and Driving Force of Nuclear Medicine Radioisotopes Market? Knows Upstream Raw Materials Sourcing and Downstream Buyers
Who are the opportunities and threats faced by the Manufacturers in Nuclear Medicine Radioisotopes space? Business Overview by Type, Applications, Gross Margin and Market Share
What are the market opportunities, market risk and market overview of the Nuclear Medicine Radioisotopes Market?
Price of Report: $ 4250 (Single User License)
Table of Contents included in Nuclear Medicine Radioisotopes Market Report –
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by end-user industry
PART 07: Market segmentation by application
PART 08: Geographical Segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
PART 14: Appendix
List of abbreviations
List of Exhibits
Purchase full Nuclear Medicine Radioisotopes Report at http://absolutereports.com/purchase/13999554
About Absolute Reports:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Name: Ajay More
Email: [email protected]
Organization: Absolute Reports
Phone: +14242530807/+44203239 8187